Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Garlic Oil vs Metapex for Primary Molar Root Filling
NCT06755502Not yet recruiting
- Sponsor
- Cairo University
- Start
- Aug 2025
- Primary completion
- Oct 2026
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
01
Overview
Randomised trial of allium sativum oil in irreversible pulpitis and pulp necrosis (2 arms), sponsored by Cairo University. Primary endpoints: Clinical success rate at 12 months and Radio-graphic success at 12 months. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
allium sativum oil
03
Conditions
irreversible pulpitispulp necrosis
Beyond the preview
Go deeper on NCT06755502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06755502.